ManRos Therapeutics is a development-stage pharmaceutical company developing new treatments against Cystic Fibrosis, neurodegenerative diseases, and renal diseases.
A common research on three pathologies
ManRos Therapeutics develops novel drug candidates acting against severe pathologies, namely cystic fibrosis, neurodegenerative disorders (Alzheimer’s disease and Down syndrome), and some renal diseases (including polycystic kidney disease). Anomalies in phosphorylation are observed in the three pathologies on which ManRos Therapeutics carries out its research: they share common targets and similar mechanisms.
Two leading researchers
ManRos Therapeutics is the project of two specialists in cell and molecular biology and in organic chemistry:
Dr. Laurent Meijer & Pr. Hervé Galons.
March 28 – April 1st 2017 | Saint Malo, France